SCHEMBL30976299

SCHEMBL30976299

Cn1[nH]c(=O)c2cc(F)ccc2c1=O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
TP53 P04637 1/20 0.59
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ACHE P22303 1/20 0.46
ALOX5 P09917 1/20 0.42
DAO P14920 1/20 0.42
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
FEN1 P39748 2/20 0.39
ATM Q13315 1/20 0.39
PARP1 P09874 3/20 0.38
MPO P05164 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30319354 0.79 KDM4E (0.55) KDM4ETP53ALOX5DAOMPO
SCHEMBL30976381 0.78 MPO (0.44) KDM4ECA1CA2ACHEDAO
SCHEMBL17559152 0.76 KDM4E (0.56) KDM4ETP53ALDH1A1LMNAPOLB
SCHEMBL1101962 0.75 KDM4E (1.00) KDM4ETP53ALOX5ALDH1A1LMNA
SCHEMBL31091767 0.75 KDM4E (1.00) KDM4ETP53ALOX5ALDH1A1LMNA
SCHEMBL22721901 0.75 TSHR (0.67) KDM4ECA1CA2ACHEPOLB
SCHEMBL8834687 0.73 KDM4E (0.53) KDM4ETP53CA1CA2ACHE
SCHEMBL15680203 0.72 KDM4E (0.55) KDM4ETP53CA1CA2ALOX5
SCHEMBL30976328 0.71 MPO (0.44) KDM4ECA1CA2ACHEDAO
SCHEMBL3110885 0.70 DAO (0.69) KDM4EDAOALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed